HQ

HealthEquity, Inc.

HQYHealthcareNASDAQ

Health Information Services · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.31B
+9.5% YoY
Net Income
$215.2M
+122.5% YoY
EBITDA
$489.2M
+44.3% YoY
Free Cash Flow
$370.3M

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 72.8, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 70.3, above 70, stock may be overbought
About HealthEquity, Inc.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. With a market capitalization of $8.19B, it sits in mid-cap territory. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool.

Key stats
Market Cap$8.19B
P/E (TTM)36.58
Fwd P/E17.93
EPS$2.67
Beta0.21
52W Change-0.0%
ROE11.1%
Analysis

The company holds $265.4M in cash, though total debt stands at $984.7M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $370.3M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 11.1%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 6.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $861.7M (2023) to $1.31B (2026), reflecting a 52% increase over the period.

With a beta below 0.7, HealthEquity, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing HQY.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms